DMAC
DiaMedica Therapeutics Inc
8.20$
-1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -100.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +484.6% | -100.0% | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | – | -2.9% | – | – | +12.6% | +22.6% | – | – | -7.0% | +1.5% | -99.8% | +58,833.3% | -99.8% | +16.7% | -14.3% | +91,916.7% | -14.1% | +8.8% | -99.8% | +0.0% | +25.0% | +68,730.0% | -99.8% | +0.0% | -72.7% | +500.0% | -22.2% | -21.4% | – | – | |
| – | – | – | – | – | – | – | – | – | -100.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -42.8% | +173.1% | -21.1% | -46.3% | +31.9% | +22.4% | +35.3% | +13.1% | +99.0% | +8.3% | -28.1% | -13.7% | +11.4% | -25.1% | +18.6% | +34.9% | +44.6% | -22.9% | -10.4% | +8.2% | -19.8% | +5.5% | -1.0% | -16.1% | +38.4% | +59.4% | -29.7% | +28.7% | +12.4% | 0.0% | +6.9% | +26.9% | +29.8% | -12.6% | +2.9% | +10.6% | +4.1% | +19.2% | +2.1% | – | |
| – | -17.0% | -26.5% | +37.3% | +23.7% | +230.6% | -32.3% | +51.5% | -0.4% | -37.0% | +66.3% | +6.5% | +20.4% | -7.3% | +9.0% | +5.0% | +4.8% | -1.1% | +5.7% | -0.3% | -10.3% | +26.8% | +13.6% | -9.8% | +5.6% | +14.4% | +11.7% | +15.5% | -14.2% | +15.2% | -4.9% | -17.2% | +11.1% | +2.6% | +27.7% | -12.2% | +18.8% | -3.2% | -0.8% | -6.0% | – | |
| – | -36.9% | +112.5% | -15.0% | -34.4% | +61.5% | +12.3% | +41.7% | +7.4% | -100.2% | – | -19.9% | -2.9% | +4.1% | -13.2% | +12.6% | +22.6% | +28.6% | -15.2% | -7.0% | +1.5% | -5.0% | +8.9% | -4.9% | -7.0% | +27.0% | +39.0% | -14.1% | +8.8% | +13.4% | -1.8% | -1.8% | +22.1% | +22.3% | -3.3% | -1.7% | +12.8% | +2.0% | +13.8% | -3.3% | – | |
| – | -36.9% | +112.5% | -15.0% | -34.4% | -261.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +19.6% | -15.5% | -91.9% | +7.1% | +86.8% | +89.1% | -66.9% | +485.6% | +124.3% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | +400.0% | -62.9% | +484.6% | +109.2% | +3,524.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -17.1% | +14.9% | +16.6% | -10.7% | -408.1% | – | +1,045.6% | +248.2% | -91.9% | +92.4% | -11.1% | +50.0% | -83.3% | +350.0% | +0.0% | -77.8% | +250.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +214.3% | -68.2% | +0.0% | +0.0% | +28.6% | -33.3% | +0.0% | +0.0% | +66.7% | -170.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.